You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
奧翔藥業(603229.SH)連續3個漲停提示風險 滾動市盈率為75.46倍
格隆匯 02-07 17:46

格隆匯2月7日丨奧翔藥業(603229.SH)公佈,公司股票於2020年2月4日、2月5日、2月6日連續三個交易日內收盤價格漲幅偏離值累計超過20%,公司已於2020年2月7日披露了《股票交易異常波動公告》。2020年2月7日公司股票再次漲停。鑑於近期公司股票價格波動較大,現就公司有關事項和風險説明如下:

一、公司當前市盈率明顯高於行業水平

根據中國證監會發布的行業分類結果,公司所處行業為醫藥製造業。經查詢中證指數有限公司官網,截至2020年2月7日收盤,公司滾動市盈率為75.46倍,醫藥製造業的滾動市盈率為37.71倍,公司當前市盈率明顯高於行業水平。公司目前總股本為16000萬股,流通盤較小。敬請廣大投資者注意二級市場交易風險,理性決策,審慎投資。

二、公司產品結構、主營業務未發生重大變化

公司目前經營狀況正常,內外部經營環境未發生重大變化,目前產品結構和主營業務均未發生重大變化。

三、匯率波動風險

公司出口業務佔主營業務收入的比重較高,主要採用美元等外幣進行結算,因此,當匯率出現較大波動時,匯兑損益對公司的經營業績會造成一定的影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account